Searched for
APRISO
Alembic Pharma jumps over 6% on getting approval from USFDA for Mesalamine extended-release capsules“The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Apriso Extended-Release Capsules, 0.375 g, of ...- Alembic Pharma receives final approval from USFDA for generic Mesalamine extended-release capsulesThe approved drug is therapeutically equivalent to Salix Pharmaceuticals Inc's reference listed drug (RLD), Apriso extended-release capsule...
- Pharma’s perennial underperformer gets a shot in the arm. Can it deliver?The stock has gained 64 per cent from March lows and 27 per cent year to date, but still 54 per cent down from its all-time high of Rs 2,12...
- Equirus retains reduce on Lupin, target price Rs 684Reduce Lupin Ltd. at a price target of Rs 684.0 .
- Analyst Calls: Bajaj Auto, Mindtree, Lupin, DB CorpJefferies has an underperform rating on Bajaj Auto with a target price of Rs 2,650.
- Dassault Systemes to acquire US firm Apriso for $ 205 millionDesign software firm Dassault Systemes today said it will acquire US-based software company Apriso for about $ 205 million.
Load More